ImmuMap is delighted to announce the formation of our advisory board
ImmuMap is proud to welcome four distinguished strategic advisors as our first members of the Advisory Board.
Jeppe Andersen, Michael Bauer, Morten Birkeland and Stefan Glück are joining and comprising the board to help shape and guide the strategy of ImmuMap to achieve our ambitious goal of becoming the leading provider of tailored T cell assays for pharmaceutical applications working closely with the leadership team. With their transformative ideas and significant experience from leading pharmaceutical companies and the world of startups and clinical trial conduct, we believe ImmuMap will be able to achieve this goal as we continue to develop our portfolio of assays and services.
Detailed biographies of our Advisory Board members can be found here.
At ImmuMap we strive to advance T cell immune monitoring efforts in the field of immune oncology, autoimmunity and safety assessment by our customized flow cytometry solutions. We apply our expertise for generating pivotal data packages needed by our clients in the discovery, pre-clinical and clinical stage of their drug development programs.